Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

IJ Pharmaceutical Research

Home
Current IssueAll IssuesIn PressAccepted Manuscripts
SearchInstructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. The effect of dexmedetomidine on clinical and management outcomes in patients with septic shock: A systematic review and meta-analysis of randomized trials

- Alsagban A. , et al.

2. Dexmedetomidine to Reduce Vasopressor Resistance in Refractory Septic Shock: α2 Agonist Dexmedetomidine for REfractory Septic Shock (ADRESS): A Double-Blind Randomized Controlled Pilot Trial

- Dargent A. , et al.

3. Combining O2 High Flow Nasal or Non-Invasive Ventilation with Cooperative Sedation to Avoid Intubation in Early Diffuse Severe Respiratory Distress Syndrome, Especially in Immunocompromised or COVID Patients?

- Petitjeans F. , et al.

4. The efficacy of dexmedetomidine for septic shock: A meta-analysis of randomized controlled trials

- Huang X. , et al.

5. Improved understanding of the respiratory drive pathophysiology could lead to earlier spontaneous breathing in severe acute respiratory distress syndrome

- Petitjeans F. , et al.

6. Dexmedetomidine only regimen for long-term sedation is associated with reduced vasopressor requirements in septic shock patients: A retrospective cohort study from MIMIC-IV database

- Li L. , et al.

7. Dexmedetomidine to reduce vasopressor resistance in refractory septic shock: Protocol for a double-blind randomized controlled pilot trial (ADRESS Pilot study)

- Dargent A. , et al.

8. Is the sympathetic system detrimental in the setting of septic shock, with antihypertensive agents as a counterintuitive approach? A clinical proposition

- Petitjeans F. , et al.

9. Is the autonomic nervous system explaining norepinephrine requirements decrease in septic shock patients following administration of alpha-2 agonists?

- Dargent A. , et al.